NCT02121444View on ClinicalTrials.gov

BAY86-5046 (Betaseron), Non Interventional Studies

CompletedOBSERVATIONAL

Enrollment

151

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

March 9, 2016

Study Completion Date

June 1, 2016

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon beta-1b (Betaferon, BAY 86-5046)

DEVICE

BETACONNECT auto-injector.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY